![Andrew Cheng](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andrew Cheng
Directeur/Membre du Conseil chez
VERA THERAPEUTICS, INC.
Fortune : 621 174 $ au 31/05/2026
Profil
Andrew Cheng is currently an Independent Director at Vera Therapeutics, Inc. since 2017 and a Director at Boys & Girls Clubs of Metro Los Angeles.
Formerly, Dr. Cheng was President, Chief Executive Officer & Director at Akero Therapeutics, Inc. from 2018 to 2025; Independent Director at Arbutus Biopharma Corp.
from 2019 to 2022; Director at Syntimmune, Inc.; Director at Global Virus Network; Non-Executive Director at MorphoSys AG from 2022 to 2024; and Chief Medical Officer & Executive Vice President at Gilead Sciences, Inc. in 2018.
Education includes an undergraduate degree from The Johns Hopkins University in 1988 and a doctorate from Columbia University College of Physicians & Surgeons in 1996.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 21/05/2026 | 17 488 ( 0,02% ) | 621 174 $ | 31/05/2026 |
Postes actifs de Andrew Cheng
| Sociétés | Poste | Début |
|---|---|---|
| VERA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/05/2017 |
Boys & Girls Clubs of Metro Los Angeles
 Boys & Girls Clubs of Metro Los Angeles Miscellaneous Commercial ServicesCommercial Services Operates as a Non-profit organization that provides proven programming services | Directeur/Membre du Conseil | - |
Anciens postes connus de Andrew Cheng
| Sociétés | Poste | Fin |
|---|---|---|
| AKERO THERAPEUTICS, INC. | Directeur Général | 09/12/2025 |
| MORPHOSYS AG | Directeur/Membre du Conseil | 06/06/2024 |
| ARBUTUS BIOPHARMA CORPORATION | Directeur/Membre du Conseil | 25/05/2022 |
| GILEAD SCIENCES, INC. | Directeur Technique/Scientifique/R&D | 07/09/2018 |
Syntimmune, Inc.
 Syntimmune, Inc. BiotechnologyHealth Technology Engages in developing novel antibody therapies and severe toxicities in bio pharma industry | Directeur/Membre du Conseil | - |
Formation de Andrew Cheng
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
87
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Arbutus Biopharma Corp.
 Arbutus Biopharma Corp. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics which targets viral diseases | Health Technology |
Syntimmune, Inc.
Syntimmune, Inc. BiotechnologyHealth Technology Engages in developing novel antibody therapies and severe toxicities in bio pharma industry | Health Technology |
MorphoSys AG
 MorphoSys AG BiotechnologyHealth Technology Manufactures pharmaceutical products and provides research and development services | Health Technology |
The Johns Hopkins University
 The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Global Virus Network
 Global Virus Network Miscellaneous Commercial ServicesCommercial Services Researches on essential and critical defense against viral disease | Commercial Services |
Columbia University College of Physicians & Surgeons
 Columbia University College of Physicians & Surgeons Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Akero Therapeutics, Inc.
 Akero Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for patients with metabolic diseases | Health Technology |
Vera Therapeutics, Inc.
 Vera Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company, which focuses on development and treatments for immunological & inflammatory diseases | Health Technology |
Boys & Girls Clubs of Metro Los Angeles
Boys & Girls Clubs of Metro Los Angeles Miscellaneous Commercial ServicesCommercial Services Operates as a Non-profit organization that provides proven programming services | Commercial Services |
